The oncology space is undergoing a tremendous amount of innovation, as novel new products and practices become available. But those treatments can do only so much good if oncologists aren’t using them. Precision’s Christy Banach and Janet Serluco weigh in on the opportunity biopharma companies have to differentiate themselves from their competitors by addressing oncologists’ specific needs.
Read the full article here!